Skip to main content

Table 2 Biopsy yield, quality, safety, and acceptance of biopsy procedure for gluteus medius myofascial trigger point (GTP) and descending trapezius myofascial trigger point (TTP) samples and control (vastus lateralis) samples

From: Evaluation of mitochondrial function in chronic myofascial trigger points - a prospective cohort pilot study using high-resolution respirometry

 

GTP (n = 10)

TTP (n = 10)

Vastus Lateralis (n = 20)

Mean biopsy yield (mg)

3.7 ± 1.6

3.4 ± 2.2

3.8 ± 2.1

Mean microscopic biopsy quality (1–5)a

4.9 ± 0.32

4.7 ± 0.48

4.7 ± 0.47

Clinical wound assessment (number of patients without signs for local infection and inflammation), n

10

10

20

Mean ultrasonic volume of hematoma (cm3)

0

0

0

Surgical complications, n

0

0

0

Mean pain (NRS) at biopsy location after 7 days

0.25 ± 0.35

1.1 ± 2.3

0.2 ± 0.4

Procedure burden at biopsy location (1–4)b

3.2 ± 0.8

3.1 ± 0.99

3.1 ± 0.91

  1. Values are mean ± SD
  2. aMicroscopic biopsy quality scale of 1–5: 1 = poor, 2 = fair, 3 = good, 4 = very good, and 5 = excellent
  3. bProcedure burden scale of 1–4: 1 = very high, 2 = high, 3 = low, and 4 = none
  4. NRS Numeric Rating Scale